Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the response and safety in subjects receiving the
drugs lenalidomide and azacitidine when each drug is given by itself and when the drugs are
taken together. This study is open for patients with relapsed or refractory follicular or
marginal zone lymphoma.